Literature DB >> 15739645

Developing a paediatric asthma review pro forma.

Harrop Michele1, Laweh Amegavie.   

Abstract

BACKGROUND: Accurate record keeping can enhance patient care by promoting continuity and consistency of management, and aid evaluation of clinical practice. To improve paediatric asthma management, the paediatric respiratory team in a large district general hospital developed a pre-printed asthma review sheet (pro forma) for use at asthma follow-up clinics in the paediatric outpatient department. To assess the pro forma's effectiveness, the team examined the quality of clinical documentation during a retrospective audit of entries in the case notes of 100 patients, and compared it with that in 100 completed pro formas. The completed pro formas contained information on general progress, symptom severity and management of the child since the last medical review.
CONCLUSION: The pro forma was shown to improve overall documentation. It not only aided the collection of relevant, clinically useful information, thereby helping clinicians to make decisions on management regimens, but it, also proved to be a valuable assessment tool for the management of chronic asthma in children.

Entities:  

Mesh:

Year:  2005        PMID: 15739645     DOI: 10.7748/ns2005.02.19.22.33.c3803

Source DB:  PubMed          Journal:  Nurs Stand        ISSN: 0029-6570


  2 in total

1.  Introduction of Asthma APGAR tools improve asthma management in primary care practices.

Authors:  Barbara P Yawn; Susan Bertram; Peter Wollan
Journal:  J Asthma Allergy       Date:  2008-08-31

2.  A comparison of mental state examination documentation by junior clinicians in electronic health records before and after the introduction of a semi-structured assessment template (OPCRIT+).

Authors:  Sarah E M Lobo; James Rucker; Madeleine Kerr; Fidel Gallo; Giles Constable; Matthew Hotopf; Robert Stewart; Matthew Broadbent; Martin Baggaley; Simon Lovestone; Peter McGuffin; Myanthi Amarasinghe; Stuart Newman; Gunter Schumann; Philip J Brittain
Journal:  Int J Med Inform       Date:  2015-05-19       Impact factor: 4.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.